#6200 on the rich list of 14,452 insiders
David P. Schenkein
Director at Agios Pharmaceuticals; Director at Denali Therapeutics; Director at Regeneron Pharmaceuticals. Based in South San Francisco, California.
$15.7M
in disclosed stock, −$467K (−2.89%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 6200th of 14,452
- Companies held
- 3
- Largest holding
- AGIO, 87.3% of total
- Latest SEC filing
- Jun 3, 2026
What the $15.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Agios Pharmaceuticals AGIO Common stock | Through David P. Schenkein 2004 Revocable Trust | 270,772 | $28.76 | $7.8M | 49.6% | Form 4, Jun 13, 2024 |
| Agios Pharmaceuticals AGIO Common stock | Directly | 126,242 | $28.76 | $3.6M | 23.1% | Form 4, Jun 13, 2024 |
| Agios Pharmaceuticals AGIO Common stock | Through Amy P. Schenkein 2004 Revocable Trust | 79,082 | $28.76 | $2.3M | 14.5% | Form 4, Jun 13, 2024 |
| Denali Therapeutics DNLI Common Stock | Through Amy P. Schenkein 2004 Revocable Trust | 31,232 | $18.20 | $568K | 3.6% | Form 4, Jun 3, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 603 | $923.34 | $557K | 3.5% | Form 4, Jan 2, 2026 |
| Denali Therapeutics DNLI Common Stock | Through David P. Schenkein 2004 Revocable Trust | 26,232 | $18.20 | $477K | 3.0% | Form 4, Jun 3, 2026 |
| Denali Therapeutics DNLI Common Stock | Directly | 21,665 | $18.20 | $394K | 2.5% | Form 4, Jun 3, 2026 |
Share counts are the amounts David P. Schenkein reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6197 | Stephen W. Bershad Director, Mission Produce. Oxnard, CA | $15.7M |
| 6198 | John T. Thomas Director, Healthpeak Properties. Denver, CO | $15.7M |
| 6199 | David W. Guggina Executive Vice President, Walmart. Bentonville, AR | $15.7M |
| 6200 | David P. Schenkein Director, Agios Pharmaceuticals. South San Francisco, CA | $15.7M |
| 6201 | John Wesley Hardin PRES. - ELECTRONIC INSTRUMENTS, AMETEK. Berwyn, PA | $15.7M |
| 6202 | Kevin Chin Chairman & CEO, VivoPower | $15.7M |
| 6203 | Jason Christopher Dorsett 10% owner, RTB Digital. San Juan, PR | $15.7M |
Other Agios Pharmaceuticals insiders
All AGIO insiders- Brian Goff$5.3MChief Executive Officer. #13359 overall
- Jacqualyn Fouse$4.4MDirector. #10858 overall
- John Maraganore$820KDirector. #1983 overall
- Jonathan Biller$660KChief Financial Officer. #10581 overall
- Jay Backstrom$42KDirector. #4910 overall
Questions
How much stock does David P. Schenkein own?
David P. Schenkein holds $15,689,443 in listed stock based on SEC filings and current prices, mostly Agios Pharmaceuticals (AGIO). That ranks 6200th on the Stock Rich List.
Is this David P. Schenkein's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.